Your browser doesn't support javascript.
loading
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.
Venkatraman, Navin; Ndiaye, Birahim Pierre; Bowyer, Georgina; Wade, Djibril; Sridhar, Saranya; Wright, Daniel; Powlson, Jonathan; Ndiaye, Ibrahima; Dièye, Siry; Thompson, Craig; Bakhoum, Momar; Morter, Richard; Capone, Stefania; Del Sorbo, Mariarosaria; Jamieson, Sophie; Rampling, Tommy; Datoo, Mehreen; Roberts, Rachel; Poulton, Ian; Griffiths, Oliver; Ballou, W Ripley; Roman, François; Lewis, David J M; Lawrie, Alison; Imoukhuede, Egeruan; Gilbert, Sarah C; Dieye, Tandakha N; Ewer, Katie J; Mboup, Souleymane; Hill, Adrian V S.
Afiliação
  • Venkatraman N; Jenner Institute, University of Oxford, United Kingdom.
  • Ndiaye BP; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.
  • Bowyer G; Jenner Institute, University of Oxford, United Kingdom.
  • Wade D; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.
  • Sridhar S; Jenner Institute, University of Oxford, United Kingdom.
  • Wright D; Jenner Institute, University of Oxford, United Kingdom.
  • Powlson J; Jenner Institute, University of Oxford, United Kingdom.
  • Ndiaye I; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.
  • Dièye S; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.
  • Thompson C; Jenner Institute, University of Oxford, United Kingdom.
  • Bakhoum M; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.
  • Morter R; Jenner Institute, University of Oxford, United Kingdom.
  • Capone S; ReiThera Srl, Rome, Italy.
  • Del Sorbo M; ReiThera Srl, Rome, Italy.
  • Jamieson S; Jenner Institute, University of Oxford, United Kingdom.
  • Rampling T; Jenner Institute, University of Oxford, United Kingdom.
  • Datoo M; Jenner Institute, University of Oxford, United Kingdom.
  • Roberts R; Jenner Institute, University of Oxford, United Kingdom.
  • Poulton I; Jenner Institute, University of Oxford, United Kingdom.
  • Griffiths O; Jenner Institute, University of Oxford, United Kingdom.
  • Ballou WR; GlaxoSmithKline Biologicals, Rixensart, Belgium.
  • Roman F; GlaxoSmithKline Biologicals, Rixensart, Belgium.
  • Lewis DJM; National Institute for Health Research/Imperial Clinical Research Facility, Hammersmith Hospital, London, United Kingdom.
  • Lawrie A; Jenner Institute, University of Oxford, United Kingdom.
  • Imoukhuede E; Jenner Institute, University of Oxford, United Kingdom.
  • Gilbert SC; Jenner Institute, University of Oxford, United Kingdom.
  • Dieye TN; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.
  • Ewer KJ; Jenner Institute, University of Oxford, United Kingdom.
  • Mboup S; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.
  • Hill AVS; Jenner Institute, University of Oxford, United Kingdom.
J Infect Dis ; 219(8): 1187-1197, 2019 04 08.
Article em En | MEDLINE | ID: mdl-30407513
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Ebola Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Ebola Idioma: En Ano de publicação: 2019 Tipo de documento: Article